APA (7th ed.) Citation

Rodriguez‐Labrada, R., Ortega‐Sanchez, R., Hernández Casaña, P., Santos Morales, O., Padrón‐Estupiñan, M. d. C., Batista‐Nuñez, M., . . . Silva Ricardo, Y. (2022). Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study. Movement Disorders, 37(7), 1516. https://doi.org/10.1002/mds.29045

Chicago Style (17th ed.) Citation

Rodriguez‐Labrada, Roberto, et al. "Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study." Movement Disorders 37, no. 7 (2022): 1516. https://doi.org/10.1002/mds.29045.

MLA (9th ed.) Citation

Rodriguez‐Labrada, Roberto, et al. "Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study." Movement Disorders, vol. 37, no. 7, 2022, p. 1516, https://doi.org/10.1002/mds.29045.